The Prediction of Adverse Maternal Outcomes in Preeclampsia
about
Calcium supplementation during pregnancy for preventing hypertensive disorders and related problemsCalcium supplementation commencing before or early in pregnancy, or food fortification with calcium, for preventing hypertensive disorders of pregnancyCalcium supplementation during pregnancy for preventing hypertensive disorders and related problemsCalcium supplementation during pregnancy for preventing hypertensive disorders and related problemsEstimation of proteinuria as a predictor of complications of pre-eclampsia: a systematic review.Proteinuria as a predictor of complications of pre-eclampsia.Accuracy of liver function tests for predicting adverse maternal and fetal outcomes in women with preeclampsia: a systematic review.Increased MPV is not a significant predictor for preeclampsia during pregnancy.Dietary calcium supplementation for prevention of pre-eclampsia and related problems: a systematic review and commentary.Is mean platelet volume a better biomarker in pre-eclampsia?Prediction of progression to severe disease in women with late preterm hypertensive disorders of pregnancy.Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health.Calcium supplementation commencing before or early in pregnancy, or food fortification with calcium, for preventing hypertensive disorders of pregnancy.Clinical significance of serum albumin level in pregnancy-related hypertension.Calcium supplementation during pregnancy for preventing hypertensive disorders is not associated with changes in platelet count, urate, and urinary protein: a randomized control trial.Risk indicators for eclampsia in gestational hypertension or mild preeclampsia at term.Platelet count, mean platelet volume, platelet distribution width, and plateletcrit do not correlate with optical platelet aggregation responses in healthy volunteers.The Regulation of Fatty Acid Oxidation in Human Preeclampsia.Artificial neural network for normal, hypertensive, and preeclamptic pregnancy classification using maternal heart rate variability indexes.Comparing the expression patterns of placental magnesium/phosphorus-transporting channels between healthy and preeclamptic pregnancies.
P2860
Q24193799-C6771178-99DC-49DF-80DF-B5DCD92EDF89Q24194579-1EFA8255-7633-42D5-8CCC-6D0D3020ACEDQ24236570-0EE08B38-06E2-4189-A2BD-CDFA1C9E8D7AQ24245026-90C249BC-9E7B-4860-9E7F-AC2B404BA600Q33421540-6F664D01-C9DF-4585-B87D-CB1C55DF7367Q33421544-69CB8E3E-89ED-4833-875D-D37092D5FAD5Q33830864-36511504-D961-415E-AA74-B57F632049F1Q34419277-F75B4736-7590-4E48-8F55-18743EA68C98Q36848278-72A3AFF0-50DE-4EE0-BF2F-F64AB629E481Q38830775-FE39BB76-986D-43E8-8597-EDCC1AC405B2Q39238730-FCE1BE47-EF48-46AD-9C20-6B48CEBD5BEAQ44937462-C9C77912-3E89-4750-BB38-740804A7EFE4Q46302440-ECD4E667-4303-4C9D-9408-EF6849C788E9Q46329493-EED8570C-9D36-4899-B4C7-450950A828B0Q46433960-146F22B4-8C00-4B03-940F-386AEFC93272Q50669572-62A956BB-4910-457F-90F7-3B5CB01EDE9CQ51103181-AF892285-5323-424D-BC9E-4A219E82607EQ51532621-E434B292-A0AE-4DE0-9274-343184A2965FQ51611505-164870BA-BD8A-4587-A442-E521C0FF90F6Q51701907-8EBB3745-467C-4033-B573-30FBD6AF763A
P2860
The Prediction of Adverse Maternal Outcomes in Preeclampsia
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2004
@uk
name
The Prediction of Adverse Maternal Outcomes in Preeclampsia
@en
The Prediction of Adverse Maternal Outcomes in Preeclampsia
@nl
type
label
The Prediction of Adverse Maternal Outcomes in Preeclampsia
@en
The Prediction of Adverse Maternal Outcomes in Preeclampsia
@nl
prefLabel
The Prediction of Adverse Maternal Outcomes in Preeclampsia
@en
The Prediction of Adverse Maternal Outcomes in Preeclampsia
@nl
P2093
P1476
The Prediction of Adverse Maternal Outcomes in Preeclampsia
@en
P2093
James A. Russell
Jean-Marie Moutquin
Keith R Walley
Laura A. Magee
Laurie M. Ainsworth
Monica Norena
Rajashree M. Devarakonda
Ruihua Yin
Shoo K. Lee
Trevor Hamilton
P304
P356
10.1016/S1701-2163(16)30137-2
P577
2004-10-01T00:00:00Z